This was a well supported meeting directed at those who, at least in part, were genetically literate. Its objective was not clinical, though the importance of this aspect was emphasised in a paper by Nevin. While all the papers presented over the two days of the meeting were of a very high quality, the following aspects particularly interested us.
John Edwards began the meeting by considering the possible ways in which genetic disease might be prevented and concluded that true prevention means the prevention of mutations in the population. To attempt this approach we must first understand the mechanisms of mutation and the variety of mutagens to which the population is exposed. As geneity. His group have been investigating families with a view to prenatal exclusion testing. Twentyseven of 43 were fully informative groupings and of nine actual pregnancies six were informative, of which in half inheritance of the gene was unlikely (and in the other three not excluded).
The requirement for intensive interviewing during the genetic diagnostic procedure was stressed, as well as the need for longer time for those at risk. During the discussion, the importance of establishing the diagnosis in isolated cases was cited. A representative from Combat expressed surprise at the slow rate of introduction of predictive testing.
Ed Southern looked at the different orders of resolution using techniques available in molecular biology for mapping the human genome. He began by showing that only 2 to 10% of the genome actually represents coding sequences, with the majority (70%) being non-coding sequences such as introns and intragenic DNA (while mutations in the coding sequences would be deleterious, in most of the non-coding regions mutations would be neutral). Thus, the proportion of the DNA in which we may be interested, the coding sequences, reduces the size of the problem. He went on to look at the order of resolution obtained using techniques such as cloning into yeast, cosmids, etc, and analytical methods such as the use of genetic recombination, pulsed field gel electrophoresis, and sequencing gels and their potential use in helping to compile the genetic map of man.
Of great interest was his description of HTF islands (HpaII Tiny Fragments), unmethylated CpG regions which may mark the 5' end of coding regions of a gene. A total of about 30 000 HTF islands is found in the genome and these are the target of 'CpG' restriction enzymes.
In considering mutation as a cause of genetic disease, John Evans discussed both mutation in germ cells and somatic mutation. Factors influencing mutation rates, such as gene size, architecture, location, base composition, and especially CpG doublets with potential mutation via methyl C to T, and parental age, were considered. He placed great emphasis on the importance of somatic cell mutation. Such mutations are seen increasingly with age and are increased by irradiation and mutagens. 
